Predominant activation of MAP kinases and pro-destructive/pro-inflammatory features by TNF alpha in early-passage synovial fibroblasts via TNF receptor-1: failure of p38 inhibition to suppress matrix metalloproteinase-1 in rheumatoid arthritis
about
A crucial role for tumor necrosis factor receptor 1 in synovial lining cells and the reticuloendothelial system in mediating experimental arthritisMechanisms of non-opioid analgesics beyond cyclooxygenase enzyme inhibition.Activated protein C inhibits proliferation and tumor necrosis factor α-stimulated activation of p38, c-Jun NH2-terminal kinase (JNK) and Akt in rheumatoid synovial fibroblastsSelective involvement of ERK and JNK mitogen-activated protein kinases in early rheumatoid arthritis (1987 ACR criteria compared to 2010 ACR/EULAR criteria): a prospective study aimed at identification of diagnostic and prognostic biomarkers as wellVisfatin/pre-B-cell colony-enhancing factor (PBEF), a proinflammatory and cell motility-changing factor in rheumatoid arthritisCells of the synovium in rheumatoid arthritis. Macrophages.Cells of the synovium in rheumatoid arthritis. Synovial fibroblasts.IL-33 regulates TNF-α dependent effects in synovial fibroblasts.Metalloproteases as potential therapeutic targets in arthritis treatment.The Ras guanine nucleotide exchange factor RasGRF1 promotes matrix metalloproteinase-3 production in rheumatoid arthritis synovial tissue.Itraconazole inhibits TNF-α-induced CXCL10 expression in oral fibroblasts.Cellular electrophysiological principles that modulate secretion from synovial fibroblasts.ERK2 and JNK1 contribute to TNF-α-induced IL-8 expression in synovial fibroblasts.Tumor necrosis factor causes persistent sensitization of joint nociceptors to mechanical stimuli in rats.Apoptosis signal-regulating kinase 1 is mediated in TNF-α-induced CCL2 expression in human synovial fibroblasts.Inhibition of MAP kinase in synovium by treatment with tocilizumab in rheumatoid arthritis.Inhibition of inflammatory mediators and related signaling pathways by macrophage-stimulating protein in rheumatoid arthritis synovial fibroblasts.
P2860
Q33923409-C8F5825F-3440-4BE3-8F57-2D6BE3F0A758Q35005089-277DCC74-05E0-4EFB-9405-DF7220E7802EQ35130879-6F90CC46-19FB-4D52-8268-D5DB62619FD0Q35751545-1B97C78E-179D-4982-B59A-BE8E4C8CA742Q36217233-F3533450-BFE2-4E03-A554-84976D7E67E5Q36465497-CEFF0FD7-8473-46AD-9FD3-230933D3BCD7Q36465510-DB3738C0-7642-4948-80FF-0B4439E35916Q36613530-2A13BDDE-3153-47D3-8BF5-57B85F7AF6B2Q37030862-B70594C9-4034-4FD0-B7CE-D8F8B9F5D497Q37350928-5E340827-9BEA-4845-BEE5-9686D784F952Q39027402-262CA16D-74B6-4A2A-AD37-6A98AB5D4C52Q39850077-1896F088-7552-4448-BDB1-42516A2E6B2EQ41382132-B2C77F48-BB6F-4B6F-9113-BF554F0DC802Q42932971-77EE498A-0EDD-4F42-9F5F-C8D05647775CQ48659457-F082FC66-3512-4166-ADB8-632E34DFCDAAQ54561460-1B96F925-BE1C-41F6-8120-A65BFF08F122Q54593629-B1625B92-4279-43B0-9F35-0F4B6161196D
P2860
Predominant activation of MAP kinases and pro-destructive/pro-inflammatory features by TNF alpha in early-passage synovial fibroblasts via TNF receptor-1: failure of p38 inhibition to suppress matrix metalloproteinase-1 in rheumatoid arthritis
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Predominant activation of MAP ...... nase-1 in rheumatoid arthritis
@ast
Predominant activation of MAP ...... nase-1 in rheumatoid arthritis
@en
type
label
Predominant activation of MAP ...... nase-1 in rheumatoid arthritis
@ast
Predominant activation of MAP ...... nase-1 in rheumatoid arthritis
@en
prefLabel
Predominant activation of MAP ...... nase-1 in rheumatoid arthritis
@ast
Predominant activation of MAP ...... nase-1 in rheumatoid arthritis
@en
P2093
P2860
P356
P1476
Predominant activation of MAP ...... nase-1 in rheumatoid arthritis
@en
P2093
Andreas Roth
Elke Kunisch
Muktheshwar Gandesiri
Raimund W Kinne
Rando Winter
Reneé Fuhrmann
P2860
P304
P356
10.1136/ARD.2006.062521
P407
P577
2007-01-12T00:00:00Z